Long-term safety of satralizumab in neuromyelitis optica spectrum disorder (NMOSD) from SAkuraSky and SAkuraStar

By sjmartinez • July 5, 2022

Yamamura T, Weinshenker B, Yeaman MR, De Seze J, Patti F, Lobo P, von Büdingen HC, Kou X, Weber K, Greenberg B. Long-term safety of satralizumab in neuromyelitis optica spectrum disorder (NMOSD) from SAkuraSky and SAkuraStar. Mult Scler Relat Disord. 2022 Jul 5;66:104025. doi: 10.1016/j.msard.2022.104025. Epub ahead of print. PMID: 36007339.

All clinical trials, All demyelinating disease (CNS), Autoimmune diseases, Devic's syndrome, Neuromyelitis optica spectrum disorder, Patient safety,

Tags: Digestive Diseases, Publications

Exploring Sex Differences in Irritable Bowel Syndrome Prevalence, Environmental Risk, and Comorbidities: A Population-Based Cohort Study of Veterans

Gasperi M, Gerstenberger A, Naliboff B, Afari N; VA Million Veteran Program. Exploring Sex Differences in Irritable Bowel Syndrome Prevalence, Environmental Risk, and Comorbidities: A[...]

Pancreatic cancer: molecular pathogenesis and emerging therapeutic strategies

Rozengurt E, Eibl G. Pancreatic cancer: molecular pathogenesis and emerging therapeutic strategies. Signal Transduct Target Ther. 2026 Jan 3;11(1):6. doi: 10.1038/s41392-025-02499-y. PMID: 41484057; PMCID: PMC12764932.

Increased Autoimmunity Burden Is a Risk Factor for Developing Irritable Bowel Syndrome-Like Symptoms in Quiescent Inflammatory Bowel Disease

Chang A, Shahrvini B, Oh J, Prajapati DP, Baniqued M, Harmon R, Greb AC, Bonthala N, Sauk JS, Shin A, Chang L, Limketkai BN. Increased[...]